Kathryn Hacker1, Guillermina Kuan2,3, Nivea Vydiswaran1, Gerardo Chowell-Puente4, Mayuri Patel1, Nery Sanchez2, Roger Lopez2,5, Sergio Ojeda2, Brenda Lopez2, Jarrod Mousa6,7, Hannah E Maier1, Angel Balmaseda2,5, Aubree Gordon1. 1. School of Public Health, Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA. 2. Sustainable Sciences Institute, Managua, Nicaragua. 3. Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua. 4. School of Public Health, Department of Population Health Sciences, Georgia State University, Atlanta, Georgia, USA. 5. Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. 6. College of Veterinary Medicine, Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA. 7. College of Veterinary Medicine, Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.
Abstract
BACKGROUND: Human metapneumovirus (hMPV) is an important cause of pediatric respiratory infection. We leveraged the Nicaraguan Pediatric Influenza Cohort Study (NPICS) to assess the burden and seasonality of symptomatic hMPV infection in children. METHODS: NPICS is an ongoing prospective study of children in Managua, Nicaragua. We assessed children for hMPV infection via real-time reverse-transcription polymerase chain reaction (RT-PCR). We used classical additive decomposition analysis to assess the temporal trends, and generalized growth models (GGMs) were used to estimate effective reproduction numbers. RESULTS: From 2011 to 2016, there were 564 hMPV symptomatic infections, yielding an incidence rate of 5.74 cases per 100 person-years (95% CI 5.3, 6.2). Children experienced 3509 acute lower respiratory infections (ALRIs), of which 160 (4.6%) were associated with hMPV infection. Children under the age of one had 55% of all symptomatic hMPV infections (62/112) develop into hMPV-associated ALRIs and were five times as likely as children over one to have an hMPV-associated ALRI (rate ratio 5.5 95% CI 4.1, 7.4 p < 0.001). Additionally, symptomatic reinfection with hMPV was common. In total, 87 (15%) of all observed symptomatic infections were detected reinfections. The seasonality of symptomatic hMPV outbreaks varied considerably. From 2011 to 2016, four epidemic periods were observed, following a biennial seasonal pattern. The mean ascending phase of the epidemic periods were 7.7 weeks, with an overall mean estimated reproductive number of 1.2 (95% CI 1.1, 1.4). CONCLUSIONS: Symptomatic hMPV infection was associated with substantial burden among children in the first year of life. Timing and frequency of symptomatic hMPV incidence followed biennial patterns.
BACKGROUND: Human metapneumovirus (hMPV) is an important cause of pediatric respiratory infection. We leveraged the Nicaraguan Pediatric Influenza Cohort Study (NPICS) to assess the burden and seasonality of symptomatic hMPV infection in children. METHODS: NPICS is an ongoing prospective study of children in Managua, Nicaragua. We assessed children for hMPV infection via real-time reverse-transcription polymerase chain reaction (RT-PCR). We used classical additive decomposition analysis to assess the temporal trends, and generalized growth models (GGMs) were used to estimate effective reproduction numbers. RESULTS: From 2011 to 2016, there were 564 hMPV symptomatic infections, yielding an incidence rate of 5.74 cases per 100 person-years (95% CI 5.3, 6.2). Children experienced 3509 acute lower respiratory infections (ALRIs), of which 160 (4.6%) were associated with hMPV infection. Children under the age of one had 55% of all symptomatic hMPV infections (62/112) develop into hMPV-associated ALRIs and were five times as likely as children over one to have an hMPV-associated ALRI (rate ratio 5.5 95% CI 4.1, 7.4 p < 0.001). Additionally, symptomatic reinfection with hMPV was common. In total, 87 (15%) of all observed symptomatic infections were detected reinfections. The seasonality of symptomatic hMPV outbreaks varied considerably. From 2011 to 2016, four epidemic periods were observed, following a biennial seasonal pattern. The mean ascending phase of the epidemic periods were 7.7 weeks, with an overall mean estimated reproductive number of 1.2 (95% CI 1.1, 1.4). CONCLUSIONS: Symptomatic hMPV infection was associated with substantial burden among children in the first year of life. Timing and frequency of symptomatic hMPV incidence followed biennial patterns.
Authors: Kathryn M Edwards; Yuwei Zhu; Marie R Griffin; Geoffrey A Weinberg; Caroline B Hall; Peter G Szilagyi; Mary A Staat; Marika Iwane; Mila M Prill; John V Williams Journal: N Engl J Med Date: 2013-02-14 Impact factor: 91.245
Authors: Simon Pollett; Nidia S Trovão; Yi Tan; John-Sebastian Eden; Rebecca A Halpin; Jayati Bera; Suman R Das; David Wentworth; Victor Ocaña; Silvia M Mendocilla; Carlos Álvarez; Maria E Calisto; Josefina Garcia; Eric Halsey; Julia S Ampuero; Martha I Nelson; Mariana Leguia Journal: Influenza Other Respir Viruses Date: 2018-03-30 Impact factor: 4.380
Authors: B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus Journal: Nat Med Date: 2001-06 Impact factor: 53.440
Authors: Xin Wang; You Li; Maria Deloria-Knoll; Shabir A Madhi; Cheryl Cohen; Asad Ali; Sudha Basnet; Quique Bassat; W Abdullah Brooks; Malinee Chittaganpitch; Marcela Echavarria; Rodrigo A Fasce; Doli Goswami; Siddhivinayak Hirve; Nusrat Homaira; Stephen R C Howie; Karen L Kotloff; Najwa Khuri-Bulos; Anand Krishnan; Marilla G Lucero; Socorro Lupisan; Ainara Mira-Iglesias; David P Moore; Cinta Moraleda; Marta Nunes; Histoshi Oshitani; Betty E Owor; Fernando P Polack; Katherine L O'Brien; Zeba A Rasmussen; Barbara A Rath; Vahid Salimi; J Anthony G Scott; Eric A F Simões; Tor A Strand; Donald M Thea; Florette K Treurnicht; Linda C Vaccari; Lay-Myint Yoshida; Heather J Zar; Harry Campbell; Harish Nair Journal: Lancet Glob Health Date: 2020-11-26 Impact factor: 26.763